Search Results
Dec 10, 2025, 08:30 ET IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting
biopsy and lesion conspicuity on CEMResearchers (Spain): Federica Di Naro, MD, Francesca Pugliese, MD, Sofia Elisabetta Baldi Giorgi, Giuliano Migliaro, MD, Giulia Bicchierai, Chiara Bellini, MD, Jacopo Nori CucchiariPurpose: To evaluate the role of lesion conspicuity at
More news about: IceCure Medical
Dec 10, 2025, 08:14 ET Charleston Doctor George Book, MD, Launches MDVIP-Affiliated Primary Care Practice
physicians maintain unrivaled patient satisfaction scores of 96%, and its annual membership renewals consistently exceeding 90%.About George Book, MDDr. Book earned his medical degree and completed his internship and a combined Internal Medicine & Psychiatry residency, where he was
More news about: MDVIP
Dec 10, 2025, 08:01 ET Rob and Karen Hale make the largest gift in Boston Children's Hospital history to transform pediatric behavioral health
shift how children are treated in Boston and around the world."This gift is nothing short of transformational," said Kevin B. Churchwell, MD, CEO of Boston Children's Hospital. "It reflects extraordinary compassion and a shared belief that every child deserves not only physical health but
More news about: Boston Children's Hospital
Dec 10, 2025, 08:00 ET Onkos Surgical® Opens New Innovation Center for NanoCept® Antibacterial Technology
conditions.""I am excited by Onkos' commitment to bring this technology to more implants and ultimately to more patients," said Steven Gitelis, MD, Director of Rush University/MD Anderson's Orthopaedic Oncology Program and Chief Medical Officer of Onkos. "This is a unique technology that arms us, as surgeons, with
More news about: ONKOS SURGICAL
Dec 10, 2025, 08:00 ET Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, has appointed Charles Hugh-Jones, MD, FRCP (56) as a member of the Management Board, effective January 1, 2026. Mr. Hugh-Jones will serve as Global Chief Medical Officer.
More news about: Fresenius Medical Care Holdings, Inc.
Dec 10, 2025, 08:00 ET HarmonEyes Completes Acquisition of iFocus Health, Bringing AI-Powered Clarity to ADHD Treatment
eye-tracking-based ADHD medication management tool to HarmonEyes' growing human performance platformBETHESDA, Md., Dec. 10, 2025 /PRNewswire/ --
More news about: HarmonEyes
Dec 10, 2025, 08:00 ET Diakonos Oncology Awarded Multi-Million-Dollar Research Grant by the Cancer Prevention and Research Institute of Texas to Advance DOC1021 in Refractory Melanoma
with targeted therapies and immune checkpoint inhibitors, patients with refractory melanoma still have very limited options," said Ryan J. Sullivan, MD, Director of the Cutaneous Medical Oncology Program at Massachusetts General Brigham Cancer Institute. "DOC1021's personalized dendritic cell approach,
More news about: Diakonos Oncology
Dec 10, 2025, 07:45 ET Publication in Nature's Scientific Reports Reinforces Spiderwort Biotechnologies' Cellulose-Based Platform with New Findings on Neural Repair and Motor Recovery
applications.""Spinal cord injury remains one of the most challenging conditions in neurosurgery and neuroscience." Dr. Eve Tsai, MD, PhD, FRCSC, CIP., "Studies like this help grow our knowledge of potential pathways for tissue repair.""Spinal cord injury is one of the most devastating
More news about: Spiderwort Biotechnologies Inc.
Dec 10, 2025, 07:00 ET VERSABANK FOURTH QUARTER RESULTS DEMONSTRATE OPERATING LEVERAGE OF BUSINESS MODEL: STRONG GROWTH IN RPP ASSETS DRIVES RECORD REVENUE
VersaBank's 2025 annual audited Consolidated Financial Statements and Management's Discussion and Analysis ("MD&A") will be available today online at www.versabank.com/investor-relations,
More news about: VersaBank
Dec 10, 2025, 06:45 ET "Supports Steady Energy, Focus, and Metabolic Balance" - Gundry MD MCT Wellness Wins A 2025 Nourish Award for Best Supplement
whole-body wellness, Gundry MD MCT Wellness is a clear winner, and now, officially an award-winning one.Gundry MD MCT Wellness FAQHow do I use Gundry MD MCT Wellness?For optimal results, mix one scoop of Gundry MD MCT Wellness with 10 ounces of
More news about: Gundry MD
Dec 10, 2025, 06:30 ET Expert.ai Named to the RegTech100 for 2026
company's leadership in helping banks and financial institutions stay ahead of regulatory change.ROCKVILLE, Md., Dec. 10, 2025 /PRNewswire/ -- Expert.ai, a leading provider of enterprise AI solutions for business value creation,
More news about: expert.ai
Dec 10, 2025, 06:00 ET Zocdoc Reveals Evolving Patient Preferences and Trends in Third Annual What Patients Want Report
power to the patient. Eighteen years later, that mission feels more urgent — and more possible — than ever," said Zocdoc founder and CEO Oliver Kharraz, MD. "This year's report is full of shifts, from rising costs, to new ways of seeking care. But one theme stands out: even as healthcare becomes more tech-enabled,
More news about: Zocdoc Inc.
Dec 10, 2025, 06:00 ET Realtor.com® Reveals the Top Housing Markets for 2026
Baltimore-Columbia-Towson, Md.-2.6 %
More news about: Realtor.com
Dec 10, 2025, 05:28 ET Acclaro Medical Announces First National 3DMIRACL® Day: A New Era in "Glow-Up" Fiber Laser Skin Rejuvenation
after treatment."3DMIRACL is all about helping our patients look and feel their best with a treatment that fits easily into modern, busy lifestyles," said Nima Naghshineh, MD, FACS, a board-certified plastic surgeon in Pasadena, CA. "From early intervention aesthetics to a more substantial skin reset, 3DMIRACL has been a game-changer
More news about: Acclaro Corporation
Dec 10, 2025, 00:30 ET Protean and CDPG-IIM Bangalore Release 'State of DPI in India' Report
teleconsultationsNew DPIs such as ULIP, Beckn, ONDC and OCEN are reshaping logistics, commerce and credit accessSuresh Sethi, MD and CEO, Protean eGov Technologies, said: "India's DPI journey has shown the world that digital systems can be both population-scale and deeply
More news about: Protean eGov Technologies Limited
Dec 09, 2025, 23:19 ET Il Gruppo Menarini presenta i dati di fase 2 sulla combinazione di elacestrant (ORSERDU®) in pazienti affetti da carcinoma mammario metastatico (mBC) ER+, HER2- al Simposio sul cancro al seno di San Antonio del 2025
contesto della terapia combinata", spiega Virginia Kaklamani, MD, DSc, professoressa di medicina nella divisione di ematologia/oncologia presso l'UT Health San Antonio e direttrice del programma sul cancro al seno presso l'UT Health San Antonio MD Anderson Cancer Center. "Il profilo di sicurezza di elacestrant
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 19:51 ET Cardinal Infrastructure Group Inc. Announces Pricing of Initial Public Offering
available, may be obtained from: Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate Department, 1201 Wills Street, Suite 600 Baltimore, MD 21231, by telephone at (855) 300-7136 or by email at [email protected]
More news about: Cardinal Infrastructure Group Inc.
Dec 09, 2025, 19:26 ET Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Roche, Takeda, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.Guided by the motto, "Start with Integrity, Succeed through Action" Innovent maintains the highest standard of industry
More news about: Innovent Biologics
Dec 09, 2025, 16:34 ET Equinox Expands Partnership with Function to Advance A New Standard of Health by Bringing Precision to Performance
setting a new standard for how people understand their bodies," said Function Health co-founder and Chief Medical Officer Dr. Mark Hyman, MD. "Bringing that level of clarity into Equinox's performance ecosystem creates a powerful combination — empowering members to use their Function results
More news about: Equinox Group
Dec 09, 2025, 16:15 ET A broader impact: UT Health San Antonio Center for Brain Health expands care and discovery across dozens of neurological conditions
Carlayne Jackson, MD, FAAN, chair of the Department of Neurology and professor of neurology and otolaryngology at the
More news about: UT Health San Antonio
Dec 09, 2025, 16:05 ET AGNC Investment Corp. Declares Fourth Quarter Dividends on Preferred Stock
BETHESDA, Md., Dec. 9, 2025 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) ("AGNC" or the "Company") announced today that its Board of Directors has declared cash dividends on the outstanding depositary shares1
More news about: AGNC Investment Corp.
Dec 09, 2025, 16:01 ET AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for December 2025
BETHESDA, Md., Dec. 9, 2025 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for December 2025. The dividend is
More news about: AGNC Investment Corp.
Dec 09, 2025, 14:27 ET Elevance Health Foundation Expands Support for Creating Healthier Communities' Better Births Initiative
and well-being."Elevance Health Foundation is committed to addressing the root causes of maternal health disparities," said Shantanu Agrawal, MD, Chief Health Officer of Elevance Health. "Our continued partnership with CHC reflects our belief in community-led innovation, solutions that elevate
More news about: Creating Healthier Communities
Dec 09, 2025, 14:24 ET Menarini Group 於 2025 年聖安東尼奧乳癌研討會公佈 Elacestrant (ORSERDU®) 針對 ER+、HER2- 轉移性乳癌 (mBC) 患者的第 2 期聯合治療數據
「令人鼓舞的無惡化存活期數據，增強了我們對 elacestrant 在聯合治療中作為內分泌治療骨幹角色的信心。」德州大學聖安東尼奧分校健康科學中心血液學/腫瘤科醫學教授兼德州大學聖安東尼奧分校 MD 安德森癌症中心乳癌項目負責人 Virginia Kaklamani 醫學博士表示， 「Elacestrant 與 everolimus 或 abemaciclib 聯合使用的安全性特徵，與每種藥物已知的安全性特徵一致。並未發現新的安全訊號。」將於 SABCS 發表的 ELEVATE
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 14:06 ET NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure
Summit on the unique cancer needs of veterans and first responders. It featured a fireside chat from Representative Mariannette Miller-Meeks, MD, MS (IA-01), a physician and veteran of the U.S. Army. The program also brought together a diverse group of experts to discuss how veterans, firefighters,
More news about: National Comprehensive Cancer Network